Open AccessASSESSMENT OF THE EFFECTIVENESS OF CARDIOPROTECTIVE DRUGS IN TREATMENT OF CHILDREN WITH DIABETIC CARDIOMYOPATHY
Author(s) -
Negmatova Gulzoda Shukhratovna,
AUTHOR_ID
Publication year - 2022
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume04issue01-09
Subject(s) - medicine , diabetes mellitus , diabetic cardiomyopathy , cardiomyopathy , life expectancy , disease , cardiology , heart failure , cause of death , sudden cardiac death , heart disease , intensive care medicine , endocrinology , population , environmental health
The medical and social significance of type 1 diabetes mellitus (DM) throughout the world is due to early disability and high mortality in patients due to the development of complications, including those from the cardiovascular system. The increase in the life expectancy of patients with diabetes has highlighted the problem of late complications of the disease, the number of which increases with the progression of the disease. The leading cause of death in diabetic patients is cardiovascular accidents. At the same time, it was found that patients with diabetes under the age of 30 years quite often develop coronary heart disease. In addition, the progression of diabetes leads to the development of cardiomyopathy (myocardial dystrophy), myocardiosclerosis, heart failure, life-threatening cardiac arrhythmias, and sudden cardiac death.